Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$27.57−2.27 (-7.61%)
Close on Nov 18, 2026Market cap $8.51BP/E 19.7Yield –
Oscar Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Oscar Health's revenue for the twelve months ending Jun 30, 2026 was $15.32B, up 42.8% year over year. For fiscal 2025 it was $11.70B, up 27.5% from the year before. The highest annual figure on record is $11.70B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.70B | +27.5% |
| FY2024 | Dec 31, 2024 | $9.18B | +56.5% |
| FY2023 | Dec 31, 2023 | $5.86B | +47.9% |
| FY2022 | Dec 31, 2022 | $3.96B | +115.6% |
| FY2021 | Dec 31, 2021 | $1.84B | +297.3% |
| FY2020 | Dec 31, 2020 | $462.80M | -5.2% |
| FY2019 | Dec 31, 2019 | $488.19M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.88B | +70.4% |
| Q1 FY2026 | Mar 31, 2026 | $4.65B | +52.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.81B | +17.3% |
| Q3 FY2025 | Sep 30, 2025 | $2.99B | +23.2% |
| Q2 FY2025 | Jun 30, 2025 | $2.86B | +29.0% |
| Q1 FY2025 | Mar 31, 2025 | $3.05B | +42.2% |
| Q4 FY2024 | Dec 31, 2024 | $2.39B | +67.1% |
| Q3 FY2024 | Sep 30, 2024 | $2.42B | +68.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.22B | +45.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.14B | +45.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.43B | +43.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.44B | +47.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.52B | +49.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.47B | +51.1% |
| Q4 FY2022 | Dec 31, 2022 | $995.13M | +100.6% |
| Q3 FY2022 | Sep 30, 2022 | $978.43M | +120.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.02B | +92.2% |
| Q1 FY2022 | Mar 31, 2022 | $972.77M | +163.3% |
| Q4 FY2021 | Dec 31, 2021 | $496.07M | +214.6% |
| Q3 FY2021 | Sep 30, 2021 | $443.98M | +336.6% |
| Q2 FY2021 | Jun 30, 2021 | $529.28M | +358.9% |
| Q1 FY2021 | Mar 31, 2021 | $369.39M | +319.3% |
| Q4 FY2020 | Dec 31, 2020 | $157.67M | – |
| Q3 FY2020 | Sep 30, 2020 | $101.70M | – |
| Q2 FY2020 | Jun 30, 2020 | $115.33M | – |
| Q1 FY2020 | Mar 31, 2020 | $88.10M | – |
See a number that looks wrong?